NATL HEALTH INVESTORS INC (NHI) Fundamental Analysis & Valuation

NYSE:NHI • US63633D1046

Current stock price

77 USD
-0.62 (-0.8%)
At close:
77 USD
0 (0%)
After Hours:

This NHI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. NHI Profitability Analysis

1.1 Basic Checks

  • In the past year NHI was profitable.
  • In the past year NHI had a positive cash flow from operations.
  • In the past 5 years NHI has always been profitable.
  • In the past 5 years NHI always reported a positive cash flow from operatings.
NHI Yearly Net Income VS EBIT VS OCF VS FCFNHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M

1.2 Ratios

  • NHI's Return On Assets of 5.08% is amongst the best of the industry. NHI outperforms 93.44% of its industry peers.
  • NHI has a Return On Equity of 9.33%. This is amongst the best in the industry. NHI outperforms 85.25% of its industry peers.
  • NHI has a better Return On Invested Capital (5.56%) than 95.08% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for NHI is above the industry average of 3.12%.
Industry RankSector Rank
ROA 5.08%
ROE 9.33%
ROIC 5.56%
ROA(3y)5.27%
ROA(5y)4.48%
ROE(3y)10.08%
ROE(5y)8.58%
ROIC(3y)5.76%
ROIC(5y)5.44%
NHI Yearly ROA, ROE, ROICNHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • NHI's Profit Margin of 37.80% is amongst the best of the industry. NHI outperforms 91.80% of its industry peers.
  • NHI's Profit Margin has declined in the last couple of years.
  • NHI has a better Operating Margin (50.74%) than 93.44% of its industry peers.
  • In the last couple of years the Operating Margin of NHI has declined.
  • Looking at the Gross Margin, with a value of 80.86%, NHI belongs to the top of the industry, outperforming 81.97% of the companies in the same industry.
  • In the last couple of years the Gross Margin of NHI has declined.
Industry RankSector Rank
OM 50.74%
PM (TTM) 37.8%
GM 80.86%
OM growth 3Y-0.48%
OM growth 5Y-5.57%
PM growth 3Y16.56%
PM growth 5Y-7.44%
GM growth 3Y-2.16%
GM growth 5Y-3.6%
NHI Yearly Profit, Operating, Gross MarginsNHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. NHI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NHI is destroying value.
  • NHI has more shares outstanding than it did 1 year ago.
  • NHI has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, NHI has an improved debt to assets ratio.
NHI Yearly Shares OutstandingNHI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
NHI Yearly Total Debt VS Total AssetsNHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 1.92 indicates that NHI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 1.92, NHI belongs to the top of the industry, outperforming 94.26% of the companies in the same industry.
  • NHI has a Debt/Equity ratio of 0.76. This is a neutral value indicating NHI is somewhat dependend on debt financing.
  • NHI's Debt to Equity ratio of 0.76 is fine compared to the rest of the industry. NHI outperforms 75.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Altman-Z 1.92
ROIC/WACC0.72
WACC7.67%
NHI Yearly LT Debt VS Equity VS FCFNHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • NHI has a Current Ratio of 1.19. This is a normal value and indicates that NHI is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of NHI (1.19) is better than 64.75% of its industry peers.
  • A Quick Ratio of 1.19 indicates that NHI should not have too much problems paying its short term obligations.
  • The Quick ratio of NHI (1.19) is better than 65.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
NHI Yearly Current Assets VS Current LiabilitesNHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. NHI Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.34% over the past year.
  • The Earnings Per Share has been decreasing by -6.07% on average over the past years.
  • Looking at the last year, NHI shows a quite strong growth in Revenue. The Revenue has grown by 12.07% in the last year.
  • NHI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.45% yearly.
EPS 1Y (TTM)1.34%
EPS 3Y26.84%
EPS 5Y-6.07%
EPS Q2Q%-1.23%
Revenue 1Y (TTM)12.07%
Revenue growth 3Y10.53%
Revenue growth 5Y2.45%
Sales Q2Q%23.4%

3.2 Future

  • NHI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.48% yearly.
  • The Revenue is expected to grow by 12.89% on average over the next years. This is quite good.
EPS Next Y10.03%
EPS Next 2Y7.73%
EPS Next 3Y6.48%
EPS Next 5YN/A
Revenue Next Year21.74%
Revenue Next 2Y15.72%
Revenue Next 3Y16.68%
Revenue Next 5Y12.89%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NHI Yearly Revenue VS EstimatesNHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M
NHI Yearly EPS VS EstimatesNHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

2

4. NHI Valuation Analysis

4.1 Price/Earnings Ratio

  • NHI is valuated quite expensively with a Price/Earnings ratio of 25.50.
  • Based on the Price/Earnings ratio, NHI is valued a bit cheaper than 74.59% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.42, NHI is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 23.17, the valuation of NHI can be described as rather expensive.
  • 88.52% of the companies in the same industry are more expensive than NHI, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of NHI to the average of the S&P500 Index (22.24), we can say NHI is valued inline with the index average.
Industry RankSector Rank
PE 25.5
Fwd PE 23.17
NHI Price Earnings VS Forward Price EarningsNHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NHI indicates a slightly more expensive valuation: NHI is more expensive than 73.77% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.96
NHI Per share dataNHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NHI does not grow enough to justify the current Price/Earnings ratio.
  • NHI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.54
PEG (5Y)N/A
EPS Next 2Y7.73%
EPS Next 3Y6.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. NHI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.74%, NHI is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 7.42, NHI has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.81, NHI pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.74%

5.2 History

  • The dividend of NHI decreases each year by -3.59%.
  • NHI has been paying a dividend for at least 10 years, so it has a reliable track record.
  • NHI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-3.59%
Div Incr Years1
Div Non Decr Years3
NHI Yearly Dividends per shareNHI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

  • NHI pays out 119.52% of its income as dividend. This is not a sustainable payout ratio.
DP119.52%
EPS Next 2Y7.73%
EPS Next 3Y6.48%
NHI Yearly Income VS Free CF VS DividendNHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M
NHI Dividend Payout.NHI Dividend Payout, showing the Payout Ratio.NHI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NHI Fundamentals: All Metrics, Ratios and Statistics

NATL HEALTH INVESTORS INC

NYSE:NHI (4/24/2026, 8:04:00 PM)

After market: 77 0 (0%)

77

-0.62 (-0.8%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-26
Earnings (Next)05-04
Inst Owners73.55%
Inst Owner Change0.3%
Ins Owners0.99%
Ins Owner Change14.59%
Market Cap3.73B
Revenue(TTM)375.63M
Net Income(TTM)141.98M
Analysts76.67
Price Target91.16 (18.39%)
Short Float %3.59%
Short Ratio5.28
Dividend
Industry RankSector Rank
Dividend Yield 4.74%
Yearly Dividend3.61
Dividend Growth(5Y)-3.59%
DP119.52%
Div Incr Years1
Div Non Decr Years3
Ex-Date03-31
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.1%
Min EPS beat(2)-8.3%
Max EPS beat(2)-1.91%
EPS beat(4)1
Avg EPS beat(4)-1.5%
Min EPS beat(4)-8.3%
Max EPS beat(4)4.29%
EPS beat(8)4
Avg EPS beat(8)0.17%
EPS beat(12)6
Avg EPS beat(12)2.26%
EPS beat(16)7
Avg EPS beat(16)-10.94%
Revenue beat(2)2
Avg Revenue beat(2)8.55%
Min Revenue beat(2)5.78%
Max Revenue beat(2)11.32%
Revenue beat(4)4
Avg Revenue beat(4)6.17%
Min Revenue beat(4)3.26%
Max Revenue beat(4)11.32%
Revenue beat(8)8
Avg Revenue beat(8)5.58%
Revenue beat(12)11
Avg Revenue beat(12)4.1%
Revenue beat(16)12
Avg Revenue beat(16)1.1%
PT rev (1m)4.38%
PT rev (3m)3.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.4%
EPS NY rev (1m)-1.35%
EPS NY rev (3m)-1.64%
Revenue NQ rev (1m)3.19%
Revenue NQ rev (3m)7.65%
Revenue NY rev (1m)4.84%
Revenue NY rev (3m)5.98%
Valuation
Industry RankSector Rank
PE 25.5
Fwd PE 23.17
P/S 9.93
P/FCF N/A
P/OCF 15.77
P/B 2.45
P/tB 2.45
EV/EBITDA 17.96
EPS(TTM)3.02
EY3.92%
EPS(NY)3.32
Fwd EY4.32%
FCF(TTM)-1.19
FCFYN/A
OCF(TTM)4.88
OCFY6.34%
SpS7.75
BVpS31.4
TBVpS31.4
PEG (NY)2.54
PEG (5Y)N/A
Graham Number46.1897 (-40.01%)
Profitability
Industry RankSector Rank
ROA 5.08%
ROE 9.33%
ROCE 7.04%
ROIC 5.56%
ROICexc 5.6%
ROICexgc 5.62%
OM 50.74%
PM (TTM) 37.8%
GM 80.86%
FCFM N/A
ROA(3y)5.27%
ROA(5y)4.48%
ROE(3y)10.08%
ROE(5y)8.58%
ROIC(3y)5.76%
ROIC(5y)5.44%
ROICexc(3y)5.81%
ROICexc(5y)5.5%
ROICexgc(3y)5.84%
ROICexgc(5y)5.53%
ROCE(3y)7.29%
ROCE(5y)6.89%
ROICexgc growth 3Y6.24%
ROICexgc growth 5Y-1.2%
ROICexc growth 3Y6.24%
ROICexc growth 5Y-1.17%
OM growth 3Y-0.48%
OM growth 5Y-5.57%
PM growth 3Y16.56%
PM growth 5Y-7.44%
GM growth 3Y-2.16%
GM growth 5Y-3.6%
F-Score5
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Debt/EBITDA 4.29
Cap/Depr 363.26%
Cap/Sales 78.28%
Interest Coverage 3.7
Cash Conversion 87.12%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 1.92
F-Score5
WACC7.67%
ROIC/WACC0.72
Cap/Depr(3y)218.38%
Cap/Depr(5y)144.44%
Cap/Sales(3y)46.96%
Cap/Sales(5y)31.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.34%
EPS 3Y26.84%
EPS 5Y-6.07%
EPS Q2Q%-1.23%
EPS Next Y10.03%
EPS Next 2Y7.73%
EPS Next 3Y6.48%
EPS Next 5YN/A
Revenue 1Y (TTM)12.07%
Revenue growth 3Y10.53%
Revenue growth 5Y2.45%
Sales Q2Q%23.4%
Revenue Next Year21.74%
Revenue Next 2Y15.72%
Revenue Next 3Y16.68%
Revenue Next 5Y12.89%
EBIT growth 1Y1.11%
EBIT growth 3Y10%
EBIT growth 5Y-3.26%
EBIT Next Year54.77%
EBIT Next 3Y19.24%
EBIT Next 5YN/A
FCF growth 1Y-215.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.86%
OCF growth 3Y8.48%
OCF growth 5Y0.38%

NATL HEALTH INVESTORS INC / NHI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NATL HEALTH INVESTORS INC (NHI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NHI.


What is the valuation status for NHI stock?

ChartMill assigns a valuation rating of 2 / 10 to NATL HEALTH INVESTORS INC (NHI). This can be considered as Overvalued.


What is the profitability of NHI stock?

NATL HEALTH INVESTORS INC (NHI) has a profitability rating of 7 / 10.


Can you provide the financial health for NHI stock?

The financial health rating of NATL HEALTH INVESTORS INC (NHI) is 4 / 10.


Can you provide the dividend sustainability for NHI stock?

The dividend rating of NATL HEALTH INVESTORS INC (NHI) is 5 / 10 and the dividend payout ratio is 119.52%.